Elusys Therapeutics Inc.

Boca Raton, FL Doing business as Elusys

UEI
ELP1DCK8L191
CAGE
1WEK8
Primary NAICS
325412 Pharmaceutical Preparation Manufacturing
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
  • Manufacturer of Goods
Entity structure
Corporate Entity (Not Tax Exempt)
NAICS codes registered in SAM.gov
SAM.gov registration date
Physical address
7700 Congress Ave #2207, Boca Raton, FL 33487, USA
Website
elusys.com
Founded
1998
Employees
11-50
Estimated annual revenue
$1M-$10M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Pharmaceuticals
SIC code
28 Chemical & Allied Products
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Recent federal awards

Elusys Therapeutics Inc.'s 5 most recent federal contract and grant awards, newest first. Amounts are dollars obligated.
Award Agency Obligated Awarded
Anthim (obiltoxaximab) Contract · 75A50324C00006 Office of the Assistant Secretary for Preparedness and Response $124,523,123
Anthim letter contract Contract · 75A50121C00073 Office of the Assistant Secretary for Preparedness and Response $79,947,200
For other functions Contract · 75A50118F33002 Office of the Assistant Secretary for Preparedness and Response $24,501,100
For other functions Contract · HHSO10033001T Office of the Assistant Secretary for Preparedness and Response $44,971,900
Anthim IM and stability testing Contract · W9113M10C0024 ACC Redstone $734,898

About Elusys Therapeutics Inc.

Products and Services

The government contractor appears to specialize in biomedical research and development, with a focus on advanced technology. The products and services provided include "ANTHIM LETTER CONTRACT", "FOR OTHER FUNCTIONS", "BIOMEDICAL (ADVANCED)", and "BIOMEDICAL (BASIC)". Over time, the contractor has shifted from basic biomedical services to more advanced and specific contracts, such as the "ANTHIM" contracts.

Customers

The primary agencies awarding contracts to this contractor are the Department of Health and Human Services (HHS), the Department of Defense (DOD) - Army - AMC - ACC, HHS - NIH, and DOD - Navy - SECNAV. Over time, the contractor has expanded its customer base from the DOD to include HHS and NIH. The top buyers from this contractor are HHS and DOD, with HHS being the most frequent buyer.

Vehicles

The contract vehicles awarded to this contractor include Definitive Contracts and Delivery Orders. Over time, the contractor has maintained a balance between these two types of contracts, with a slight increase in Definitive Contracts.

Summary

The government contractor has a strong history of contract awards, primarily in the biomedical research and development sector. The contractor has successfully expanded its customer base over time, and has maintained a balance between Definitive Contracts and Delivery Orders. The contractor's focus on advanced biomedical services suggests a commitment to innovation and technological advancement.

Data

The analysis is based on seven contracts awarded between 09/28/04 and 08/06/21.

Quick answers

What is Elusys Therapeutics Inc.'s UEI?

Elusys Therapeutics Inc.'s Unique Entity ID (UEI) in SAM.gov is ELP1DCK8L191.

What is Elusys Therapeutics Inc.'s CAGE code?

Elusys Therapeutics Inc.'s CAGE code is 1WEK8.

What is Elusys Therapeutics Inc.'s primary NAICS code?

Elusys Therapeutics Inc.'s primary NAICS code is 325412 (Pharmaceutical Preparation Manufacturing).

Where is Elusys Therapeutics Inc. located?

Elusys Therapeutics Inc.'s physical address in SAM.gov is 7700 Congress Ave #2207, Boca Raton, FL 33487, USA.

Is Elusys Therapeutics Inc. registered in SAM.gov?

Yes. Elusys Therapeutics Inc.'s SAM.gov registration is active through March 12, 2027.

What is Elusys Therapeutics Inc.'s most recent federal award?

Elusys Therapeutics Inc.'s most recent federal contract award is Anthim (obiltoxaximab) (75A50324C00006), from Office of the Assistant Secretary for Preparedness and Response, on May 1, 2024.

On GovTribe

See Elusys Therapeutics Inc.'s full federal record

  • Federal contract awards
  • IDV awards
  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors